Advances in the Management of Prostate Cancer: The Emerging Role of ProstaScint® and Quadramet®

[摘要] Prostate cancer remains the second most common malignancy and cause of death from cancer among men in the United States, despite the profound changes in the epidemiology and management of the disease that have occurred over the past few decades.1 The progress in our understanding of the disease has led to significant advances in our therapeutic, diagnostic, and prognostic abilities. Although effective therapies continue to evolve and improve, there is yet a long way to go before we can claim victory in our war against prostate cancer.1

[学科分类] 基础医学